Royalty Pharma
RPRX
RPRX
265 hedge funds and large institutions have $10.7B invested in Royalty Pharma in 2021 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 106 increasing their positions, 66 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more capital invested
Capital invested by funds: $9.59B → $10.7B (+$1.1B)
0.31% more ownership
Funds ownership: 62.15% → 62.46% (+0.31%)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
Holders
265
Holding in Top 10
11
Calls
$49.1M
Puts
$11.2M
Top Buyers
| 1 | +$246M | |
| 2 | +$118M | |
| 3 | +$89.4M | |
| 4 |
BlackRock
New York
|
+$50M |
| 5 |
State Street
Boston,
Massachusetts
|
+$49.5M |
Top Sellers
| 1 | -$179M | |
| 2 | -$147M | |
| 3 | -$130M | |
| 4 |
Amundi
Paris,
France
|
-$48M |
| 5 |
Morgan Stanley
New York
|
-$42.8M |